Nevus, Pigmented  >>  sagopilone (BAY86-5302)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sagopilone (BAY86-5302) / Bayer
NCT00598507: Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma

Completed
2
35
US
ZK-EPO, EpothiloneZK, ZK 219477, Sagopilone
H. Lee Moffitt Cancer Center and Research Institute, Bayer
Melanoma
01/13
01/13

Download Options